do you gain weight back after semaglutide Regain Stopping Stopping Semaglutide: How to Keep

Novo Nordisk has been conducting late-stage clinical trials on higher doses of oral semaglutide, specifically 25 mg and 50 mg tablets, aimed at weight loss rather than just diabetes

No significant increase in gastroparesis diagnosis was detected compared to placebo groups in any pivotal trial

Furthermore, GLP-1 has been shown to have anti-inflammatory and cardiovascular protective effects

Clinical trials showed that patients taking semaglutide lost approximately 15% of their body weight on averagesubstantially more than older GLP-1 medications or lifestyle interventions alone

At this stage, the focus shifts toward maintenance, metabolic health, and overall wellness